[PDF][PDF] Shared and distinct functions of type I and type III interferons

HM Lazear, JW Schoggins, MS Diamond - Immunity, 2019 - cell.com
Type I interferons (IFNs)(IFN-α, IFN-β) and type III IFNs (IFN-λ) share many properties,
including induction by viral infection, activation of shared signaling pathways, and …

[HTML][HTML] Exploring the pivotal immunomodulatory and anti-inflammatory potentials of glycyrrhizic and glycyrrhetinic acids

SA Richard - Mediators of Inflammation, 2021 - hindawi.com
Licorice extract is a Chinese herbal medication most often used as a demulcent or elixir. The
extract usually consists of many components but the key ingredients are glycyrrhizic (GL) …

Hepatitis B virus infection

WM Lee - New England journal of medicine, 1997 - Mass Medical Soc
The hepatitis B virus (HBV), discovered in 1966, infects more than 350 million people
worldwide. 1 Hepatitis B is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular …

The mechanism of placebo analgesia

JD Levine, NC Gordon, HL Fields - The Lancet, 1978 - Elsevier
The effect of naloxone on dental postoperative pain was studied to examine the hypothesis
that endorphins mediate placebo analgesia. All patients had extraction of impacted …

Hepatitis B virus infection

JL Dienstag - New England Journal of Medicine, 2008 - Mass Medical Soc
More effective and less resistance-prone antiviral agents are now available to treat hepatitis
B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and …

Interferons at age 50: past, current and future impact on biomedicine

EC Borden, GC Sen, G Uze, RH Silverman… - Nature reviews Drug …, 2007 - nature.com
The family of interferon (IFN) proteins has now more than reached the potential envisioned
by early discovering virologists: IFNs are not only antivirals with a spectrum of clinical …

Update on diagnosis, management, and prevention of hepatitis B virus infection

FJ Mahoney - Clinical microbiology reviews, 1999 - Am Soc Microbiol
Acute and chronic hepatitis B virus (HBV) infection is a leading cause of liver disease
worldwide. It is estimated that approximately 350 million people worldwide have chronic …

Management of hepatitis B: 2000—summary of a workshop

AS Lok, EJ Heathcote, JH Hoofnagle - Gastroenterology, 2001 - Elsevier
Chronic infection with the hepatitis B virus (HBV) is estimated to affect 400 million persons
and to be the single most common cause of cirrhosis and hepatocellular carcinoma (HCC) …

Medical virology of hepatitis B: how it began and where we are now

WH Gerlich - Virology journal, 2013 - Springer
Infection with hepatitis B virus (HBV) may lead to acute or chronic hepatitis. HBV infections
were previously much more frequent but there are still 240 million chronic HBV carriers …

Microbial synthesis of poly (ε-lysine) and its various applications

L Shih, MH Shen, YT Van - Bioresource technology, 2006 - Elsevier
This review article deals with the microbial synthesis, physiochemical properties, and
potential applications of poly-ε-lysine (ε-PL), which is a naturally occurring biomaterial that is …